| Global Impairment of CD4+CD25+FOXP3+ Regulatory T Cells in Idiopathic Pulmonary Fibrosis I Kotsianidis, E Nakou, I Bouchliou, A Tzouvelekis, E Spanoudakis, ... American journal of respiratory and critical care medicine 179 (12), 1121-1130, 2009 | 283 | 2009 |
| Kinetics, function and bone marrow trafficking of CD4+ CD25+ FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS) I Kotsianidis, I Bouchliou, E Nakou, E Spanoudakis, D Margaritis, ... Leukemia 23 (3), 510-518, 2009 | 194 | 2009 |
| Regulation of multiple myeloma survival and progression by CD1d E Spanoudakis, M Hu, K Naresh, E Terpos, V Melo, A Reid, I Kotsianidis, ... Blood, The Journal of the American Society of Hematology 113 (11), 2498-2507, 2009 | 127 | 2009 |
| Alterations of platelet function, number and indexes during acute pancreatitis K Mimidis, V Papadopoulos, J Kotsianidis, D Filippou, E Spanoudakis, ... Pancreatology 4 (1), 22-27, 2004 | 108 | 2004 |
| Th17 and Foxp3+ T regulatory cell dynamics and distribution in myelodysplastic syndromes I Bouchliou, P Miltiades, E Nakou, E Spanoudakis, A Goutzouvelidis, ... Clinical immunology 139 (3), 350-359, 2011 | 75 | 2011 |
| Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells I Kotsianidis, JD Silk, E Spanoudakis, S Patterson, A Almeida, ... Blood 107 (8), 3138-3144, 2006 | 58 | 2006 |
| Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease A Ersek, K Xu, A Antonopoulos, TD Butters, AE Santo, Y Vattakuzhi, ... The Journal of clinical investigation 125 (6), 2279-2292, 2015 | 56 | 2015 |
| Acute effects of soccer training on white blood cell count in elite female players AA Avloniti, HT Douda, SP Tokmakidis, AH Kortsaris, EG Papadopoulou, ... International journal of sports physiology and performance 2 (3), 239-249, 2007 | 54 | 2007 |
| Activated invariant NKT cells regulate osteoclast development and function M Hu, JH Bassett, L Danks, PGT Howell, K Xu, E Spanoudakis, ... The Journal of Immunology 186 (5), 2910-2917, 2011 | 52 | 2011 |
| “Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard … E Katodritou, C Vadikolia, C Lalagianni, M Kotsopoulou, G Papageorgiou, ... Annals of hematology 93 (1), 129-139, 2014 | 49 | 2014 |
| P-wave duration and atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis S Intzes, K Zagoridis, M Symeonidou, E Spanoudakis, A Arya, B Dinov, ... Europace 25 (2), 450-459, 2023 | 47 | 2023 |
| Dynamics of telomere's length and telomerase activity in Philadelphia chromosome negative myeloproliferative neoplasms E Spanoudakis, I Bazdiara, D Pantelidou, I Kotsianidis, V Papadopoulos, ... Leukemia Research 35 (4), 459-464, 2011 | 44 | 2011 |
| Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas M Dimou, SG Papageorgiou, N Stavroyianni, E Katodritou, M Tsirogianni, ... Hematological oncology 39 (3), 336-348, 2021 | 42 | 2021 |
| The diagnostic value of CD1d expression in a large cohort of patients with B-cell chronic lymphoproliferative disorders I Kotsianidis, E Nakou, E Spanoudakis, I Bouchliou, E Moustakidis, ... American journal of clinical pathology 136 (3), 400-408, 2011 | 35 | 2011 |
| Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab‐based quadruplets: a multicenter study by the Greek myeloma study group E Katodritou, E Kastritis, D Dalampira, S Delimpasi, E Spanoudakis, ... American Journal of Hematology 98 (5), 730-738, 2023 | 31 | 2023 |
| Addition of cyclosporin-A to chemotherapy in secondary (post-MDS) AML in the elderly. A multicenter randomized trial of the Leukemia Working Group of the Hellenic Society of … P Matsouka, M Pagoni, P Zikos, N Giannakoulas, I Apostolidis, ... Annals of hematology 85 (4), 250-256, 2006 | 28 | 2006 |
| Pregnancy in β-thalassemia trait carriers: an uneventful journey C Tsatalas, P Chalkia, D Pantelidou, D Margaritis, G Bourikas, ... Hematology 14 (5), 301-303, 2009 | 27 | 2009 |
| The Stat3/5 signaling biosignature in hematopoietic stem/progenitor cells predicts response and outcome in myelodysplastic syndrome patients treated with azacitidine P Miltiades, E Lamprianidou, TP Vassilakopoulos, SG Papageorgiou, ... Clinical Cancer Research 22 (8), 1958-1968, 2016 | 23 | 2016 |
| CD1d expression as a prognostic marker for chronic lymphocytic leukemia A Anastasiadis, I Kotsianidis, V Papadopoulos, E Spanoudakis, ... Leukemia & lymphoma 55 (2), 320-325, 2014 | 22 | 2014 |
| Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival E Katodritou, MC Kyrtsonis, S Delimpasi, D Kyriakou, A Symeonidis, ... Annals of hematology 97 (9), 1671-1682, 2018 | 21 | 2018 |
